These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28233295)

  • 1. DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
    Ronchetti L; Melucci E; De Nicola F; Goeman F; Casini B; Sperati F; Pallocca M; Terrenato I; Pizzuti L; Vici P; Sergi D; Di Lauro L; Amoreo CA; Gallo E; Diodoro MG; Pescarmona E; Vitale I; Barba M; Buglioni S; Mottolese M; Fanciulli M; De Maria R; Maugeri-Saccà M
    Int J Cancer; 2017 Jun; 140(11):2587-2595. PubMed ID: 28233295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression.
    Di Benedetto A; Ercolani C; Mottolese M; Sperati F; Pizzuti L; Vici P; Terrenato I; Shaaban AM; Humphries MP; Di Lauro L; Barba M; Vitale I; Ciliberto G; Speirs V; De Maria R; Maugeri-Saccà M
    Sci Rep; 2017 Aug; 7(1):8078. PubMed ID: 28808232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of PD-L1 in advanced gastric cancer is dependent on
    Buglioni S; Melucci E; Sperati F; Pallocca M; Terrenato I; De Nicola F; Goeman F; Casini B; Amoreo CA; Gallo E; Diodoro MG; Pescarmona E; Vici P; Sergi D; Pizzuti L; Di Lauro L; Mazzotta M; Barba M; Fanciulli M; Vitale I; De Maria R; Ciliberto G; Maugeri-Saccà M
    Oncoimmunology; 2018; 7(8):e1457602. PubMed ID: 30221053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis.
    Vici P; Di Benedetto A; Ercolani C; Pizzuti L; Di Lauro L; Sergi D; Sperati F; Terrenato I; Dattilo R; Botti C; Fabi A; Ramieri MT; Mentuccia L; Marinelli C; Iezzi L; Gamucci T; Natoli C; Vitale I; Barba M; Mottolese M; De Maria R; Maugeri-Saccà M
    Oncotarget; 2015 Dec; 6(40):42773-80. PubMed ID: 26544894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis.
    Vici P; Buglioni S; Sergi D; Pizzuti L; Di Lauro L; Antoniani B; Sperati F; Terrenato I; Carosi M; Gamucci T; Dattilo R; Bartucci M; Vincenzoni C; Mariani L; Vizza E; Sanguineti G; Gadducci A; Vitale I; Barba M; De Maria R; Mottolese M; Maugeri-Saccà M
    PLoS One; 2016; 11(3):e0149872. PubMed ID: 26930412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lycopene inhibits Helicobacter pylori-induced ATM/ATR-dependent DNA damage response in gastric epithelial AGS cells.
    Jang SH; Lim JW; Morio T; Kim H
    Free Radic Biol Med; 2012 Feb; 52(3):607-615. PubMed ID: 22178412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage signaling is activated during cancer progression in human colorectal carcinoma.
    Oka K; Tanaka T; Enoki T; Yoshimura K; Ohshima M; Kubo M; Murakami T; Gondou T; Minami Y; Takemoto Y; Harada E; Tsushimi T; Li TS; Traganos F; Darzynkiewicz Z; Hamano K
    Cancer Biol Ther; 2010 Feb; 9(3):246-52. PubMed ID: 20023412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint.
    Lin X; Chen D; Zhang C; Zhang X; Li Z; Dong B; Gao J; Shen L
    J Exp Clin Cancer Res; 2018 Jun; 37(1):129. PubMed ID: 29954437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
    Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
    Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of irradiation-induced repair foci in mouse embryonic stem cells].
    Suvorova II; Pospelov VA
    Tsitologiia; 2014; 56(5):340-5. PubMed ID: 25696973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression.
    An J; Huang YC; Xu QZ; Zhou LJ; Shang ZF; Huang B; Wang Y; Liu XD; Wu DC; Zhou PK
    BMC Mol Biol; 2010 Mar; 11():18. PubMed ID: 20205745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting DNA Damage Repair Pathways in Pancreatic Adenocarcinoma.
    Das S; Cardin D
    Curr Treat Options Oncol; 2020 Jun; 21(8):62. PubMed ID: 32601814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
    Melucci E; Casini B; Ronchetti L; Pizzuti L; Sperati F; Pallocca M; De Nicola F; Goeman F; Gallo E; Amoreo CA; Sergi D; Terrenato I; Vici P; Di Lauro L; Diodoro MG; Pescarmona E; Barba M; Mazzotta M; Mottolese M; Fanciulli M; Ciliberto G; De Maria R; Buglioni S; Maugeri-Saccà M
    J Transl Med; 2018 Feb; 16(1):22. PubMed ID: 29402328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATR- and ATM-Mediated DNA Damage Response Is Dependent on Excision Repair Assembly during G1 but Not in S Phase of Cell Cycle.
    Ray A; Blevins C; Wani G; Wani AA
    PLoS One; 2016; 11(7):e0159344. PubMed ID: 27442013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma.
    Zhang ZZ; Liu YJ; Yin XL; Zhan P; Gu Y; Ni XZ
    World J Gastroenterol; 2013 Mar; 19(12):1968-74. PubMed ID: 23569343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.
    Barba M; Vici P; Pizzuti L; Di Lauro L; Sergi D; Di Benedetto A; Ercolani C; Sperati F; Terrenato I; Botti C; Mentuccia L; Iezzi L; Gamucci T; Natoli C; Vitale I; Mottolese M; De Maria R; Maugeri-Saccà M
    BMC Cancer; 2017 Feb; 17(1):101. PubMed ID: 28166748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer.
    Gralewska P; Gajek A; Marczak A; Rogalska A
    J Hematol Oncol; 2020 Apr; 13(1):39. PubMed ID: 32316968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
    Smith J; Tho LM; Xu N; Gillespie DA
    Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress.
    Yan S; Sorrell M; Berman Z
    Cell Mol Life Sci; 2014 Oct; 71(20):3951-67. PubMed ID: 24947324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.
    Alkema NG; Tomar T; van der Zee AG; Everts M; Meersma GJ; Hollema H; de Jong S; van Vugt MA; Wisman GB
    Gynecol Oncol; 2014 Jun; 133(3):591-8. PubMed ID: 24657486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.